Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
<h4>Background</h4>Familial hypercholesterolemia (FH) is an autosomal codominant disorder caused by mutations in the low-density lipoprotein receptor (LDLR) gene. Homozygous FH patients (hoFH) have severe hypercholesterolemia leading to life threatening atherosclerosis in childhood and a...
Guardado en:
Autores principales: | Sadik H Kassim, Hui Li, Luk H Vandenberghe, Christian Hinderer, Peter Bell, Dawn Marchadier, Aisha Wilson, Debra Cromley, Valeska Redon, Hongwei Yu, James M Wilson, Daniel J Rader |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e79587d53a7b4820b632c5dfd2a0f483 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Regression of Atherosclerosis: Insights from Animal and Clinical Studies
por: Jonathan E. Feig
Publicado: (2014) -
Genetic basis of hypercholesterolemia in adults
por: Seyedmohammad Saadatagah, et al.
Publicado: (2021) -
PROPORTION OF PSORIASIS IN FAMILIAL HYPERCHOLESTEROLEMIA
por: Samip Sheth, et al.
Publicado: (2021) -
The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population
por: R. H. Fairoozy, et al.
Publicado: (2017) -
Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma S, et al.
Publicado: (2019)